Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Takeshi Higa"'
Autor:
Shinobu Kiyuna, Jiro Miyamoto, Taichi Uehara, Hideki Sakiyama, Takeshi Higa, Takeshi Yagi, Koichi Nakanishi, Takehiro Matsuda, Tokiko Oshiro, Satoru Hamada, Nobuyuki Hyakuna
Publikováno v:
Pediatric Hematology Oncology Journal, Vol 6, Iss 4, Pp 171-174 (2021)
Background The prognosis of high-risk osteosarcoma, defined by the presence of chemo-resistance, metastatic disease at diagnosis, and relapse, remains poor. The efficacy of high-dose chemotherapy (HDC) and autologous stem-cell transplantation (ASCT)
Publikováno v:
International Journal of Hematology. 106:266-268
In the present study, we sought to evaluate the prophylactic use of octreotide for asparaginase-induced acute pancreatitis. We reviewed the medical records of seven patients in two institutions who received prophylactic octreotide for re-administrati
Autor:
Iwao Nakazato, Nobuyuki Hyakuna, Takehiro Matsuda, Kiyoshi Oshiro, Yoshihisa Miyazato, Tsukasa Nakama, Shirou Iraha, Tsukasa Kinjyo, Naoto Kuroda, Takeshi Higa
Publikováno v:
Urology. 97
This report describes an unusual case of sarcomatoid carcinoma of the bladder in a 3-year-old girl. Although saving the patient's life is most essential, it is also essential to consider quality of life. The patient underwent neoadjuvant chemotherapy
Autor:
Kazuhiro Kogawa, Yasuo Horikoshi, Asayuki Iwai, Masaki Itoh, Yasuto Shimomura, Masahito Tsurusawa, Atsushi Ogawa, Junichi Ueyama, Yutaka Saiwakawa, Hirokazu Kanegane, Masahiko Okada, Takashi Taga, Junko Yamanaka, Takeshi Higa, Arata Watanabe
Publikováno v:
Pediatric Blood & Cancer. 57:36-40
Background The aim of the JCCLSG AML 9805 Down study was to evaluate the effect of continuous and high-dose cytarabine combined chemotherapy on the survival outcome of acute myeloid leukemia (AML) with Down syndrome (DS). Procedure From May 1998 to D
Autor:
Tokiko Oshiro, Satoru Hamada, Takeshi Yagi, Nobuyuki Hyakuna, Takehiro Matsuda, Taichi Uehara, Koichi Nakanishi, Takeshi Higa, Shinobu Kiyuna, Jiro Miyamoto
Publikováno v:
Pediatric Blood & Cancer. 65:e26982
Purpose Pericardial effusion (PE) is a potentially life-threatening complication following hematopoietic stem cell transplantation (HCT). A higher incidence of early-onset PE, unrelated to graft-versus-host disease, before day 100 after HCT has been
Autor:
Tadao Orii, Shunji Tomatsu, Nobuyuki Hyakuna, Yasutsugu Chinen, Takeshi Higa, Yasuyuki Suzuki
Publikováno v:
Molecular Genetics and Metabolism Reports
Molecular Genetics and Metabolism Reports, Vol 1, Iss C, Pp 31-41 (2014)
Molecular Genetics and Metabolism Reports, Vol 1, Iss C, Pp 31-41 (2014)
Mucopolysaccharidosis IVA (MPS IVA) is one of the lysosomal storage diseases. It is caused by the deficiency of N-acetylgalactosamine-6-sulfate sulfatase. Deficiency of this enzyme leads to accumulation of the specific glycosaminoglycans keratan sulf
Autor:
Mutsuro Ohira, H Kawamoto, Hiroshi Matsubara, Takeshi Higa, M Sumi, Y Takaue, Ako Hosono, A Kaneko, Atsushi Makimoto, J Takayama, S Murayama, S Sakiyama
Publikováno v:
Bone Marrow Transplantation. 35:763-766
The prognosis of patients with metastatic retinoblastoma is poor with conventional chemotherapy and radiation. Since retinoblastoma is highly chemosensitive, dose-escalation of chemotherapeutic agents with stem cell support should be promising. We re
Autor:
Atsushi Makimoto, Takeshi Higa, Mutsuro Ohira, Ryuji Tanosaki, Takeshi Saito, Hiroshi Matsubara, Yoichi Takaue, Yoshinobu Kanda, Jun Takayama, Shin Mineishi
Publikováno v:
Japanese Journal of Clinical Oncology. 31:30-34
Background: The benefits of allogeneic peripheral blood stem/progenitor cell transplantation (PBSCT) over bone marrow transplantation (BMT), if any, have not been seriously evaluated in a pediatric population. We report here our experience with this
Autor:
Naoki Sakata, Xinan Wang, Seiji Kojima, Hideki Muramatsu, Satoshi Ueda, Yinyan Xu, Takeshi Higa, Hirotoshi Sakaguchi, Toshihiro Yamaguchi, Tsukasa Takemura
Publikováno v:
International journal of hematology. 100(5)
Juvenile myelomonocytic leukemia (JMML) is a mixed myeloproliferative and myelodysplastic disorder that occurs in early childhood. The clinical course of JMML is highly variable. A third of patients follow a relatively indolent course, although appro
Autor:
Keiko Nomura, Motoaki Chin, Masahito Tsurusawa, Miyo Yamagata, Tomoko Kuno, Takashi Taga, Hideaki Maeba, Akiko Muto, Asayuki Iwai, Takeshi Higa, Toshinori Hori
Publikováno v:
Cancer chemotherapy and pharmacology. 53(3)
To determine the minimum levels of l-asparaginase (ASNase) activity necessary to maintain l-asparagine (Asn) depletion under ASNase treatment in acute lymphoblastic leukemia (ALL). We measured ASNase activity using an enzyme coupling method with a li